Theraflu Extra Lemon 650mg+10mg+20mg powder for oral solution with lemon flavour

国家: 亚美尼亚

语言: 英文

来源: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

有效成分:

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

可用日期:

Famar Orleans

ATC代码:

N02BE51

INN（国际名称）:

paracetamol, phenylephrine (phenylephrine hydrochloride), pheniramine (pheniramine maleate)

剂量:

650mg+10mg+20mg

药物剂型:

powder for oral solution with lemon flavour

每包单位数:

(10) sachets 15g

处方类型:

OTC

授权状态:

Registered

授权日期:

2019-06-05

产品特点

N O V A R T I S
Global Drug Regulatory Affairs
THERAFLU EXTRA LEMON
Powder in Sachets
Actives substances
Paracetamol 650mg; Pheniramine maleate 20mg;
Phenylephrine hydrochloride 10mg;
SUMMARY OF PRODUCT CHARACTERISTICS
Property of Novartis Consumer Health
SA Confidential
May not be used, divulged, published or otherwise
disclosed without the consent of Novartis Consumer Health
SA
TABLE OF CONTENTS
1.
NAME OF THE MEDICINAL PRODUCT
.........................................................................
3
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
.............................................. 3
3.
PHARMACEUTICAL FORM
..............................................................................................
3
4.
CLINICAL PARTICULARS
.................................................................................................
3
4.1 THERAPEUTIC INDICATIONS
................................................................................................
3
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
................................................................... 3
4.3.
CONTRAINDICATIONS
.......................................................................................................
3
4.4.
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
.................................................... 4
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION ......... 4
4.6.
PREGNANCY AND LACTATION
.............................................................................................
5
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
............................................................ 5
4.8.
UNDESIRABLE EFFECTS
.......................................................................................................6
4.9.
OVERDOSE
.......................................................................................................................
6
5.
PHARMACOLOGICAL PROPERTIES
..............................................................................
7
5.1.
PHARMACODYNA